6 Needs context
Cortisol levels begin rising approximately 30 minutes before waking up.
"So about 30 minutes before waking, your cortisol starts to rise. It's part of the mechanism that wakes you up without an alarm clock." (said at 0:09:13)
Cortisol levels do begin to rise during the second half of the night several hours prior to waking as part of the normal endogenously driven circadian rhythm. However, characterizing this specifically as starting "about 30 minutes before waking" mixes up two distinct circadian phenomena: the broad pre-awakening rise in cortisol (which typically begins 4 to 5 hours before waking, following a nocturnal nadir around sleep onset/midnight) and the Cortisol Awakening Response (CAR), which is a rapid, steep spike in cortisol levels occurring 30 to 45 minutes *after* waking up.
- context: Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System. (International journal of environmental research and public health 2021) · cited 233x in the literature
"Lower levels of cortisol were seen at the beginning of sleep, while there was a rise towards the end of sleep, with the highest level reached at the moment the individual wakes up." (abstract, results, passage verified)
pubmedfull study (doi) - context: Is the cortisol awakening response truly a response to awakening? Replication and extensio… (European journal of applied physiology 2025) · cited 2x in the literature
"Results demonstrated that the CAR only significantly deviates from the pre-awakening rise when the pre-awakening linear rise is considered 4 (β = 1.79, 95% CI = 0.49-3.09, p = 0.007) or 5 (β = 1.79, 95% CI = 0.49-3.09, p = 0.007) h before waking." (abstract, results, passage verified)
pubmedfull study (doi)
Rapid eye movement sleep is critical for removing the emotional charge of previous-day memories and experiences.
"rapid eye movement sleep is critical for removing the emotional load of previous day and previous day memories and experiences." (said at 0:17:26)
The statement reflects the prominent "Sleep to Forget, Sleep to Remember" (SFSR) neurobiological model, which posits that REM sleep depotentiates the emotional tone of memories while preserving their factual content. Experimental neuroimaging and targeted reactivation studies show that REM sleep physiology—specifically adrenergic suppression paired with amygdala-hippocampal reactivation—is associated with decreased next-day amygdala reactivity and attenuated subjective arousal to emotional stimuli. However, systematic reviews and meta-analyses note that empirical findings across human behavioral and psychophysiological studies remain mixed, with some paradigms showing attenuation, maintenance, or even enhancement of emotional reactivity across sleep intervals.
- supports: REM sleep depotentiates amygdala activity to previous emotional experiences. (Current biology : CB 2011) · cited 382x in the literature
"Here, we demonstrate that REM sleep physiology is associated with an overnight dissipation of amygdala activity in response to previous emotional experiences, altering functional connectivity and reducing next-day subjective emotionality." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Targeted memory reactivation in REM but not SWS selectively reduces arousal responses. (Communications biology 2021) · cited 46x in the literature
"Our results show that TMR during REM, but not SWS significantly decreased subjective arousal, and this effect is driven by the more negative stimuli. These results support one aspect of the sleep to forget, sleep to remember (SFSR) hypothesis which proposes that emotional memory reactivation during REM sleep underlies sleep-dependent habituation." (abstract, results, passage verified)
pubmedfull study (doi) - context: Preferential consolidation of emotional reactivity during sleep: A systematic review and m… (Frontiers in behavioral neuroscience 2022) · cited 12x in the literature
"Findings have been inconsistent: some show that sleep attenuates emotional reactivity, whereas others report enhanced or maintained reactivity. Across-study methodological differences may account for discrepant findings." (abstract, results, passage verified)
pubmedfull study (doi)
Adrenaline and epinephrine released from the adrenal glands and the locus coeruleus form the biological basis of flashbulb memories and trigger memory consolidation.
"By the way, sorry, I didn't mean to interrupt, but you know that the origin of flashbulb memory is adrenaline. You know, it's adrenaline released from the adrenals and in the locus coeruleus, sort of a quote-unquote alertness center, although my neuroscience colleagues are going to be like, "There he goes calling brain structures by their function." But, you know, it releases epinephrine into the brain in kind of a sprinkling fashion." (said at 0:37:38)
The speaker accurately captures the broad neurobiological mechanism by which emotional arousal and stress hormones enhance memory consolidation (frequently studied in relation to emotionally salient and flashbulb-like memories). However, the statement contains a neurochemical imprecision: the locus coeruleus is the primary central source of norepinephrine (noradrenaline), not epinephrine (adrenaline). Epinephrine released peripherally from the adrenal medulla does not readily cross the blood-brain barrier; instead, it signals via the vagus nerve to activate central noradrenergic pathways, including the locus coeruleus, which then projects diffusely throughout the brain (including the basolateral amygdala and hippocampus) to modulate synaptic plasticity and long-term memory consolidation.
Ketamine is an FDA-approved drug used to dissociate emotions in therapeutic contexts.
"drugs like ketamine, you know, FDA-approved drug for dissociating your emotions while in the presence of" (said at 1:00:56)
Ketamine is an FDA-approved drug, but its FDA approval is specifically as a general anesthetic (and its S-enantiomer, esketamine, is FDA-approved for treatment-resistant depression). While ketamine produces dissociative effects and is widely used off-label in psychiatric and psychotherapeutic contexts (ketamine-assisted psychotherapy), the FDA has not approved ketamine specifically for 'dissociating emotions' or as an adjunct to psychotherapy.
Clinical trials showed up to 67% PTSD remission or significant reduction from two sessions of MDMA with a qualified therapist in a clinical setting.
"very impressive clinical trials showing up to 67% even remission of PTSD or significant reduction in PTSD from people that did two sessions of MDMA with a qualified therapist in a clinical setting." (said at 1:01:20)
Phase 3 randomized controlled trials of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) demonstrate robust efficacy in reducing PTSD symptoms compared to therapy with placebo. In the pivotal Phase 3 trial (Mitchell et al., 2021), 67% of participants who received MDMA-assisted therapy no longer met the diagnostic criteria for PTSD at the study endpoint (compared to 32% in the placebo group). However, the standard clinical trial protocol utilized three experimental MDMA sessions (alongside preparatory and integrative therapy sessions), rather than two sessions.
Most neuroplasticity occurring after birth is driven by the selective removal and pruning of connections rather than the formation of new connections.
"and most of the wiring that occurs after we're born, the so-called neuroplasticity, is a selective removal of connections as opposed to the formation of new connections." (said at 2:39:00)
During neural development, brain connectivity is initially established through an overproduction of synapses, followed by widespread activity-dependent selective elimination (pruning) of redundant connections through childhood and adolescence. However, substantial de novo synaptogenesis continues to occur after birth—with peak synaptic density in the human cerebral cortex reached between 3 months (auditory cortex) and over 15 months (prefrontal cortex) postnatally before net elimination predominates. Furthermore, adult neuroplasticity relies on a dynamic balance of new synapse formation, pruning, and functional synaptic strengthening (such as long-term potentiation), rather than being driven solely or overwhelmingly by synapse removal.
- supports: Role of neuron-glia interactions in developmental synapse elimination. (Brain research bulletin 2017) · cited 20x in the literature
"During the embryonic development of the nervous system there is a massive formation of synapses. However, the exuberant connectivity present after birth must be pruned during postnatal growth to optimize the function of neuronal circuits." (abstract, results, passage verified)
pubmedfull study (doi) - context: Regional differences in synaptogenesis in human cerebral cortex. (The Journal of comparative neurology 1997) · cited 3108x in the literature
"Synapse formation in both cortical regions begins in the fetus, before conceptual age 27 weeks. Synaptic density increases more rapidly in auditory cortex, where the maximum is reached near postnatal age 3 months. Maximum synaptic density in middle frontal gyrus is not reached until after age 15 months. Synaptogenesis occurs concurrently with dendritic and axonal growth and with myelination of the subcortical white matter. A phase of net synapse elimination occurs late in childhood, earlier in auditory cortex, where it has ended by age 12 years, than in prefrontal cortex, where it extends to midadolescence." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.